Search Results - William C. Dougall

Refine Results
  1. 1
    Targeting RANKL in metastasis

    Targeting RANKL in metastasis by William C. Dougall, Ingunn Holen, Eva González‐Suárez

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    The Involvement of Multiple Tumor Necrosis Factor Receptor (TNFR)-associated Factors in the Signaling Mechanisms of Receptor Activator of NF-κB, a Member of the TNFR Superfamily

    The Involvement of Multiple Tumor Necrosis Factor Receptor (TNFR)-associated Factors in the Signaling Mechanisms of Receptor Activator of NF-κB, a Member of the TNFR Superfamily by Laurent Galibert, Mark Tometsko, Dirk Anderson, David Cosman, William C. Dougall

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response.

    Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response. by Gary Visner, William C. Dougall, James M. Wilson, Ian A. Burr, Harry S. Nick

    Published 1990
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Ligand and p185c-neu density govern receptorinteractions and tyrosine kinase activation.

    Ligand and p185c-neu density govern receptorinteractions and tyrosine kinase activation. by Arabinda Samanta, Charles LeVea, William C. Dougall, Xiaolan Qian, M.I. Greene

    Published 1994
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    A RANK/TRAF6-dependent Signal Transduction Pathway Is Essential for Osteoclast Cytoskeletal Organization and Resorptive Function

    A RANK/TRAF6-dependent Signal Transduction Pathway Is Essential for Osteoclast Cytoskeletal Organization and Resorptive Function by Allison Armstrong, Mark Tometsko, Moira Glaccum, Claire L. Sutherland, David Cosman, William C. Dougall

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Heterodimerization of epidermal growth factor receptorand wild-type or kinase-deficient Neu: a mechanism of interreceptor kinaseactivation and transphosphorylation.

    Heterodimerization of epidermal growth factor receptorand wild-type or kinase-deficient Neu: a mechanism of interreceptor kinaseactivation and transphosphorylation. by Xiaolan Qian, Charles LeVea, J K Freeman, William C. Dougall, Mark I. Greene

    Published 1994
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    RANK Overexpression in Transgenic Mice with Mouse Mammary Tumor Virus Promoter-Controlled RANK Increases Proliferation and Impairs Alveolar Differentiation in the Mammary Epithelia and Disrupts Lumen Formation in Cultured Epithelial Acini

    RANK Overexpression in Transgenic Mice with Mouse Mammary Tumor Virus Promoter-Controlled RANK Increases Proliferation and Impairs Alveolar Differentiation in the Mammary Epithelia... by Eva González‐Suárez, Daniel Branstetter, Allison Armstrong, Huyen Dinh, Hal Blumberg, William C. Dougall

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    RANKL acts directly on RANK‐expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes

    RANKL acts directly on RANK‐expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes by Allison Armstrong, Robert E. Miller, Jon C. Jones, Jian Zhang, Evan T. Keller, William C. Dougall

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis

    RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis by Robert E. Miller, Martine P. Roudier, Jon C. Jones, Allison Armstrong, Jude Canon, William C. Dougall

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy

    Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy by Stephen J. Blake, William C. Dougall, John J. Miles, Michele W.L. Teng, Mark J. Smyth

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    RANK and RANK ligand expression in primary human osteosarcoma

    RANK and RANK ligand expression in primary human osteosarcoma by Daniel Branstetter, Kathy Rohrbach, Liya Huang, R Soriano, Mark Tometsko, Michelle Blake, Allison P. Jacob, William C. Dougall

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis

    Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis by Pasquale Pellegrini, Álex Cordero, Marta I. Gallego, William C. Dougall, Purificacı́on Muñoz, Miguel Ángel Pujana, Eva González‐Suárez

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Osteoclast Differentiation Is Impaired in the Absence of Inhibitor of κB Kinase α

    Osteoclast Differentiation Is Impaired in the Absence of Inhibitor of κB Kinase α by Michelle Chaisson, Daniel Branstetter, Jonathan M.J. Derry, Allison Armstrong, Mark Tometsko, Kiyoshi Takeda, Shizuo Akira, William C. Dougall

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain

    The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain by Mariapia A. Degli‐Esposti, William C. Dougall, Pamela J. Smolak, Jennifer Y. Waugh, Craig A. Smith, Raymond G. Goodwin

    Published 1997
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer

    RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer by Elizabeth Ahern, Heidi Harjunpää, Jake S. O’Donnell, Stacey Allen, William C. Dougall, Michele W.L. Teng, Mark J. Smyth

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer

    An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer by Alexander Liede, Rohini K. Hernandez, Sally Wade, Ronghai Bo, Nathan C. Nussbaum, Elizabeth Ahern, William C. Dougall, Mark J. Smyth

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy

    RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy by Hatem A. Azim, Fedro A. Peccatori, Sylvain Brohée, Daniel Branstetter, Sherene Loi, Giuseppe Viale, Martine Piccart, William C. Dougall, Giancarlo Pruneri, Christos Sotiriou

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice

    Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice by Elizabeth Ahern, Heidi Harjunpää, Deborah S. Barkauskas, Stacey Allen, Kazuyoshi Takeda, Hideo Yagita∥, David Wyld, William C. Dougall, Michele W.L. Teng, Mark J. Smyth

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Effects of receptor activator of NFκB (RANK) signaling blockade on fracture healing

    Effects of receptor activator of NFκB (RANK) signaling blockade on fracture healing by Lisa M. Flick, Jason M. Weaver, Michael Ulrich‐Vinther, F.S. Abuzzahab, Xinping Zhang, William C. Dougall, Dirk Anderson, Regis J. O’Keefe, Edward M. Schwarz

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity

    CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity by Amelia Roman Aguilera, Viviana P. Lutzky, Deepak Mittal, Xian-Yang Li, Kimberley Stannard, Kazuyoshi Takeda, Günter Bernhardt, Michele W.L. Teng, William C. Dougall, Mark J. Smyth

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: